Global Microbiome Manufacturing Market Size To Exceed USD 146.5 Billion By 2035 | CAGR of 16.94%

Category: Healthcare

RELEASE DATE Sep 2025
REPORT ID SI15589

Global Microbiome Manufacturing Market Size To Exceed USD 146.5 Billion By 2035

According to a research report published by Spherical Insights & Consulting, The Global Microbiome Manufacturing Market Size is expected to grow from USD 26.2 Billion in 2024 to USD 146.5 Billion by 2035, at a CAGR of 16.94% during the forecast period 2025-2035.

Microbiome Manufacturing Market

Get more details on this report -

Request Free Sample PDF

Browse key industry insights spread across 240 pages with 121 Market data tables and figures & charts from the report on the "Global Microbiome Manufacturing Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Probiotics, live biotherapeutics, Postbiotics, Prebiotics, Microbiome-targeted Therapeutics, and Others), By Manufacturing Process (Fermentation, Downstream Processing, Formulation & Packaging, and Quality Control & Testing), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035."   Get Detailed Report Description Here:  https://www.sphericalinsights.com/reports/microbiome-manufacturing-market

 

The microbiome manufacturing market refers to the industry comprising the development and production of therapies and products derived from beneficial microorganisms for health and agriculture. There is an increasing need for effective medicine, drugs, and cancer therapies is escalating the growth of microbiome manufacturing. The growth of probiotics and advanced microbiome-based therapeutics, with increased demand for personalized healthcare contributing to promoting the microbiome manufacturing market. An increasing pipeline of microbiome-based therapies is driving the microbiome manufacturing market. On the contrary, strict regulatory requirements and increased product prices are restraining the market growth.

 

The probiotics segment dominated the market with a major market share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the microbiome manufacturing market is divided into probiotics, live biotherapeutics, postbiotics, prebiotics, microbiome-targeted therapeutics, and others. Among these, the probiotics segment dominated the market with a major market share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Probiotic manufacturing involves probiotic fermentation, nitrogen freezing, and freeze drying. The growing health awareness and its therapeutic application are driving the market of microbiome manufacturing.

 

The fermentation segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the manufacturing process, the microbiome manufacturing market is divided into fermentation, downstream processing, formulation & packaging, and quality control & testing. Among these, the fermentation segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Controlled bioreactors are used for cultivating and sustaining high-density cultures of target strains within the regulatory requirements. The increasing popularity of fermented foods and beverages is contributing to market growth.

 

North America is expected to hold the majority share of the global microbiome manufacturing market during the forecast period.

 

Microbiome Manufacturing Market

Get more details on this report -

Request Free Sample PDF

North America is expected to hold the majority share of the global microbiome manufacturing market during the forecast period. An increasing collaboration with contract manufacturing organizations that offer technical expertise across different scales of operations is propelling the market growth. Further, the presence of biotech companies pioneering live microbial therapeutics in the region is driving the market.

 

Asia Pacific is anticipated to grow at the fastest pace in the global Microbiome Manufacturing market during the forecast period. An increasing demand for personalized health information and wellness solutions contributes to promoting market growth. Further, increasing R&D investment and high production capacity by the governments and institutions contribute to enhancing the market.

 

Major vendors in the global microbiome manufacturing market are Seres Therapeutics, Ferring Pharmaceuticals, Vedanta Biosciences, Finch Therapeutics, Rebiotix (a Ferring Company), BiomX, 4D Pharma, Synlogic, Enterome, Second Genome, Microbiotica, BioGaia, Prokarium, ActoBio Therapeutics, AOBiome, and Others.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Key Market Development 

  • In February 2025, MicrobioTx, a young research-based gut microbiome company, launched a new range of probiotics designed for addressing various wellness needs. The flagship probiotics line features formulations such as DigesTx, MoodTx, GlucoTx, and LeanTx.
  • In February 2025, MGI Tech Co. Ltd., a company committed to building core tools and technologies, launched the latest Microbiome Metabarcoding Sequencing Package (“MMSP”), specifically designed to support scientists in microbiome research.
  • In January 2025, Biohm Technologies, a specialist in microbiome research, ingredients, and products, announced the launch of a Longevity Gut Report functionality within its gut microbiome test kits.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the microbiome manufacturing market based on the below-mentioned segments:

 

Global Microbiome Manufacturing Market, By Product Type

  • Probiotics
  • Live biotherapeutics
  • Postbiotics
  • Prebiotics
  • Microbiome-targeted Therapeutics
  • Others

 

Global Microbiome Manufacturing Market, By Manufacturing Process

  • Fermentation
  • Downstream Processing
  • Formulation & Packaging
  • Quality Control & Testing

 

Global Microbiome Manufacturing Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies